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Abstract
Genetic association studies of complex traits often rely on standardised quantitative phenotypes, such as percen-
tage of predicted forced expiratory volume and body mass index to measure an underlying trait of interest (eg
lung function, obesity). These phenotypes are appealing because they provide an easy mechanism for comparing
subjects, although such standardisations may not be the best way to control for confounders and other covari-
ates. We recommend adjusting raw or standardised phenotypes within the study population via regression. We
illustrate through simulation that optimal power in both population- and family-based association tests is attained
by using the residuals from within-study adjustment as the complex trait phenotype. An application of family-
based association analysis of forced expiratory volume in one second, and obesity in the Childhood Asthma
Management Program data, illustrates that power is maintained or increased when adjusted phenotype residuals
are used instead of typical standardised quantitative phenotypes.
Keywords: body mass index, confounding factors, covariate adjustment, forced expiratory volume, heritable quantitative
traits
Introduction
Failure to adjust for confounders and other covariates
can greatly diminish the efﬁciency of genetic associ-
ation studies. Traditional regression methods that
control for confounders often apply directly to
genetic association studies, and these techniques
have been extended and adapted in settings where
this is not the case.
1–3 Despite this, researchers con-
ducting genetic association studies of quantitative
traits do not always take full advantage of their
ability to adjust for important covariates.
Covariate adjustment is so crucial for traits like
body mass index (BMI) and percentage of pre-
dicted forced expiratory volume in one second
(PPFEV) that they are standardised by deﬁnition.
B M I( i n s t e a do fw e i g h t )i su s e da sam e a s u r eo f
obesity because height contributes noise to the
relationship between obesity and weight. Similarly,
PPFEV , the amount of air a person can blow out
in one second divided by the expected amount,
given the person’s sex, height and, sometimes,
other covariates, is used as a measure of lung func-
tion instead of unadjusted forced expiratory
volume (FEV) because sex, height and other cov-
ariates add noise to the relationship between lung
function and FEV . To determine expected FEV ,
various equations have been proposed, each a
regression equation ﬁt to a speciﬁc study popu-
lation.
4–6 Both BMI and PPFEV were developed
to assess phenotypes in individuals when there are
no population data available — for example,
determining the severity of asthma or obesity
during physical examination.
Standardised phenotypes were not, however,
intended to serve as a substitute for within-study
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association studies have sample sizes large enough
to adjust using the study population itself, it is
no longer necessary to rely on standardisations
based on external populations. It is especially
important to adjust within the study population
when the study population is clearly dissimilar to
the general population. Consider a study popu-
lation living at high altitude: using PPFEV with
predicted FEV estimated based on a population
dwelling at sea level could make even asthmatics
seem healthy.
To determine whether researchers conducting
genetic association studies of FEVactually adjust for
confounders using the study population, we per-
formed a literature search using PubMed. Of 26
genetic association studies with FEV as a main
outcome published in the past three years, only 14
used within-study adjusted FEV .
7–19 The 12 studies
that did not mention within-study adjustment
included one that stated, ‘No covariate adjustment
was used since the percent-predicted lung function
is already covariate adjusted’.
20–31 The studies also
varied as to what potential confounders were avail-
able (for instance, many studies did not record
height). Our literature search showed that there is
no consensus on whether standardised phenotypes
should be further adjusted.
We hypothesised that within-study adjustment of
standardised quantitative phenotypes increases
power in genetic association studies. To test this,
we compared power obtained using PPFEV with
and without within-study adjustment under both
population- and family-based designs via simu-
lation. We also examined the effects of applying
within-study adjustment to raw FEV as opposed to
PPFEV and of having an ascertainment condition.
Finally, we applied the different methods to the
Childhood Asthma Management Program
(CAMP).
Materials and methods
Simulated genotypes
To simulate a family-based design, either 100, 400
or 800 independent trios (two parents and an
offspring) were generated. We assumed Hardy–
Weinberg equilibrium and drew parental alleles
from a binomial distribution with the probability of
carrying the risk allele equal to allele frequency
(0.05, 0.10 or 0.20). Offspring genotypes were
then based on Mendelian transmission. We assumed
there were no genotyping errors. For the simulated
population-based design, only offspring genotypes
were used.
Simulated raw phenotypes
Height, weight and age were generated using a
multivariate normal distribution with means and
covariances equal to those observed in a real dataset
(CAMP). We restricted our samples to Caucasian
males, to create a more homogeneous population
to which a simple set of prediction equations
would apply.
The primary unadjusted phenotype of interest,
FEV , was generated in two ways: ﬁrst with the
relationship between FEV and its confounders
based on that observed in real data, and, secondly,
with the aim of determining what happens in the
worst-case scenario for within-study adjustment —
that is, when the FEV prediction equations really
do describe the mean of the distribution of FEV . In
the ﬁrst case, FEV was simulated from a normal
distribution with mean:
aXi þ 1:522 þ 0:0271 height þ 0:000197 height2
þ 0:0219 age þ 0:00345 weight
(where a is the additive genetic effect and Xi is the
number of copies of the allele of interest), and var-
iance set equal to the variance of the residuals cal-
culated when this model was ﬁt to CAMP data.
This model describes the relationship between
height, age, weight and FEV in the CAMP study
but with an additive genetic effect (heritability of
FEV ¼ 0.01, 0.025 or 0.05).
32 The second way we
generated FEV was similar, except that the model
used to specify the mean and the variance of the
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aXi þ Iðage , 12Þð 2:814 þ 0:0348 heightÞ
þ Iðage   12Þð 6:118 þ 0:0519 height
þ 0:0636 ageÞ
That is, we set the mean equal to the FEV pre-
diction equation derived by Knudson et al. for
Caucasian males.
4 By simulating the data two ways,
we can see how much within-study adjustment
affects power under a realistic setting and also
whether it diminishes power when it is unnecessary
(ie when the FEV prediction equation explains the
exact relationship between FEV and its confoun-
ders). To examine the effect of phenotype trunca-
tion, the simulations were repeated with an
ascertainment condition, excluding all subjects with
PPFEV   80 per cent. (Final sample sizes were still
100, 400 and 800 trios.) This mimics the CAMP
dataset, which includes only children with mild to
moderate asthma.
Methods of adjustment and analysis
Four confounder-adjustment methods were applied
to obtain four corresponding phenotypes used in
genetic association testing: centred FEV , centred
PPFEV , residuals from regressing FEV on relevant
covariates and residuals from regressing PPFEV on
relevant covariates. PPFEV was calculated using the
prediction equations derived by Knudson et al.
4
Population-based association testing was done by
regressing phenotype on genotype, assuming an
additive model and performing a Wald test to
check whether the regression coefﬁcient for geno-
type is equal to zero. Family-based association
testing was done using the family-based association
test (FBAT).
33 In the population-based simulations,
FEV and PPFEV were regressed on the number of
copies of the risk allele. Within-study adjustment
was accomplished by including relevant covariates
in the regression model.
Results
Simulations
Both population- and family-based association
studies were simulated under varying allele frequen-
cies, heritabilities and sample sizes. In each case,
the power was estimated for four phenotypes:
centred FEV , PPFEV , residuals from regressing FEV
on relevant covariates and residuals from regressing
PPFEV on relevant covariates. Simulated data were
based on a real dataset and on the Knudson FEV
prediction equation, with both unascertained and
ascertained samples (Figure 1 and Supplementary
Tables S1–4). In all cases, using FEV without
adjustment was least powerful and within-study
adjusted FEV most powerful. Results were similar
for family-based and population-based simulations.
When the data were generated to resemble the
CAMP study population as closely as possible, the
most powerful approach used the residuals from
within-study adjustment of FEV , followed by
within-study adjusted PPFEV , PPFEV and ﬁnally
FEV . Within-study adjustment led to gains in
power of up to 20.5 per cent in population-based
analyses and up to 17.6 per cent in family-based
analyses. To determine how much of the variance
in FEV and PPFEV was determined by covariates,
we calculated the R
2 from regressing FEV and
PPFEV on height, weight and age under each of
the simulation settings. Because the variance of
the distribution of FEV was ﬁxed in the simu-
lations, covariates consistently explained 82–86
per cent of variance in FEV . Covariates still
explained 22–26 per cent of the variation in
PPFEV , which explains why within-study adjust-
ment increased power more so than simply calcu-
lating PPFEV .
When the data were simulated based on the FEV
prediction equations, PPFEV , within-study adjust-
ment of FEV and within-study adjusted PPFEV , all
yielded approximately equal power, since the model
assumed in the FEV prediction equation was truly
the expected value of FEV . Covariates only
explained 3–8 per cent of the variation in PPFEV .
Even in this case, where the confounding relation-
ship between FEV and covariates was wholly
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within-study adjustment did not diminish power.
The results were similar when the samples were
truncated to include only subjects with PPFEV
 80 per cent. Power decreased overall owing to
the decreased amount of variation in FEV , but the
trends in power were the same as in the untrun-
cated simulations. In fact, the within-study adjust-
ment led to even greater gains in power in the
truncated analyses: within-study adjustment led to
gains in power of up to 23.3 per cent in
population-based analyses and up to 20.4 per cent
in family-based analyses.
Data analysis: Childhood Asthma
Management Program
We demonstrated the four methods of confounder-
adjustment using CAMP , a multicentre, randomised
clinical trial including 1,041 children between ﬁve
and 14 years of age with mild to moderate
asthma.
34 The present analysis included 711 geno-
typed Caucasian trios. Each of six single nucleotide
polymorphisms (SNPs) in the gene encoding inter-
leukin 10 (IL-10), a gene previously associated with
asthma,
35–43 was tested for association with each of
four lung-function phenotypes (FEV , PPFEV ,
within-study adjusted FEV and within-study
Figure 1. Simulated power for sample size of 400 and allele frequency of 0.2. (Pattern is similar for other sample sizes and allele
frequencies.) The relationship between FEV and confounders was modelled using the CAMP data and using the equations derived by
Knudson et al.
4 Estimated power levels are for n trios simulated 10,000 times, with a type one error rate of 5 per cent. We simulated
both family and population designs, each with and without truncation. Four methods of confounder adjustment were employed: FEV,
PPFEV, residuals from regressing FEVon relevant covariates and residuals from regressing PPFEVon relevant covariates.
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ment was carried out, regressing FEV on age, sex,
weight and height (all recorded at baseline). In a
second analysis, all SNPs genotyped in the fat mass
and obesity-associated (FTO) gene, which is associ-
ated with BMI,
44 were tested for association with
six obesity phenotypes: weight, BMI and BMI
z-scores (BMIZ),
45 each with and without within-
study adjustment. Weight was adjusted for age, sex
and mean-centred height. BMI and BMIZ were
adjusted for age and sex. Neither age nor sex was a
signiﬁcant predictor of BMIZ; as a result, using
within-study adjusted BMIZ was equivalent to
using unadjusted BMIZ in this dataset. For both
analyses, the family-based association test (FBAT)
statistic was used, assuming an additive genetic
model. Regression models were ﬁt using SAS
version 9.1. All genetic association tests were per-
formed by HelixTree version 5.1.3.
After Bonferroni adjustment for multiple com-
parisons, none of the six SNPs in IL-10 were sig-
niﬁcantly associated with any of the FEV-derived
phenotypes (Figure 2). Height, weight, sex and age
explained 83.82 per cent of the variation in FEV
and 17.44 per cent of the variation in PPFEV . For
the SNP previously associated with FEV ,
rs3024496,
35 PPFEV residuals yielded the lowest
p-value (p ¼ 0.0135) followed by FEV residuals
(p ¼ 0.0317). The worst p-value for this SNP was
obtained using PPFEV . As in simulations, the
within-study adjusted phenotypes did best but,
unlike in the simulations, adjusted PPFEV
outperformed adjusted FEV and PPFEV did worse
than FEV .
No SNPs in FTO were signiﬁcant after
Bonferroni correction. The SNP previously found to
be associated with obesity, rs9939609, was not geno-
typed in CAMP . Examining quantile–quantile plots
of the –log10 p-values revealed that the association
signal was readily apparent in BMIZ (and the equival-
ent within-study adjusted BMIZ) and somewhat
apparent in within-study adjusted BMI (Figure 3).
Discussion
Our results suggest that genetic association studies
using standardised phenotypes can potentially avoid
confounding and gain power by using within-study
adjusted phenotypes, as opposed to the typical stan-
dardised form of the phenotype. Moreover, doing
so will not decrease power. Through simulations,
we showed that using within-study adjustment of
FEV or PPFEV increased power in genetic associ-
ation testing by more than using PPFEV . This was
true in both population- and family-based designs
and with and without an ascertainment condition
Table 1. IL10 SNPs genotyped.
SNP Position Location Minor
allele
freq
rs1800896 21117 A/G Promoter 0.452
rs1800871 2854 C/T Promoter 0.294
rs1800872 2672 C/A Promoter 0.289
rs3024492 1668 T/A Intron 0.225
rs3024509 2483 C/T Intron 0.054
rs3024496 3916 C/T Exon 0.451
IL10, interleukin 10.
Figure 2. Plot of –log10 power-based association test (PBAT)
p-values from testing six SNPs in IL10 for association with four
lung function phenotypes in the CAMP study.
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the FEV prediction equation used to calculate
PPFEV truly determined the relationship between
FEV and its confounders, using within-study adjust-
ment did not decrease power. Although the pre-
viously associated IL-10 SNP , rs3024496, was only
marginally signiﬁcant in the data analysis, the signal
was strongest when within-study adjustment was
used. In the FTO analysis, the distribution of
p-values from BMIZ remained unchanged after
within-study adjustment, indicating that BMIZ
effectively controlled for the available covariates in
the CAMP study population. For weight and BMI,
the association signal was enhanced by within-study
adjustment. The data analysis results must be inter-
preted with caution, since we cannot be certain that
any of the SNPs tested confer risk for decreased
lung function or obesity.
Since within-study adjustment involves ﬁtting a
model to explain how the raw phenotype is related
to confounders in the study population, it does not
provide a measure of what might be considered
normal. For this, it is still necessary to use standard-
isations based on a healthy population. For
instance, in the CAMP study, a child with ‘average’
adjusted FEV would still be considered to have low
Figure 3. Quantile–quantile plots of the –log10 (p-values) for genetic association between weight (adjusted six ways) and 166 SNPs
in the FTO gene from the CAMP study.
BMI, body mass index; BMIZ, BMI Z scores; CAMP, Childhood Asthma Management Program; SNPs, single nucleotide polymorphisms.
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have asthma. Therefore, within-study adjustment is
advantageous only if there is no need to compare
subjects’ phenotypes with what might be con-
sidered normal in the general population. The
advantage of within-study adjustment in large
studies is that it can provide a more accurate relative
measure of a complex phenotype, allowing study
subjects to be compared among themselves. In gen-
etics studies, this is precisely what is needed.
When using standardised phenotypes, the
method of standardisation can also affect study
results. Rosenfeld, et al. showed that using different
reference equations to calculate predicted FEV
leads to differences in clinical assessment of individ-
uals and in the results of cross-sectional and longi-
tudinal analyses of cystic ﬁbrosis.
46 Both the
standardisation and method of within-study adjust-
ment should be carefully thought out. Although
we only considered the Knudson equations here,
our simulation design allows the results to be gen-
eralised to other equations for predicted FEV .
In our simulations, within-study adjustment of
standardised phenotypes was always equally or less
powerful than within-study adjustment of raw pheno-
types; however, our data analysis did not reﬂect this.
The smallest p-value for the SNP previously associated
with FEV was obtained using within-study adjusted
PPFEV . Similarly, when we analysed the FTO SNPs,
the most standardised phenotype, BMIZ, performed
best (and within-study adjustment did not make a
difference). Simulated data differ from real data
because associations are simplistically modelled. Real
data are much more complex. In real data, within-
study adjustment does not fully capture the relation-
ship between raw measurements and the complex
trait of interest (eg between FEVand lung function or
between weight and obesity). By standardising and
then using the study population to adjust further, it is
possible to make use of two sources of information:
the reference population used to derive the standardis-
ation and the study population. Standardisation may
also be the only way to account for confounders not
collected in a particular study. For these reasons, it
m a yb ea d v a n t a g e o u st od og e n e t i ca s s o c i a t i o nt e s t i n g
on within-study adjusted, standardised phenotypes.
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Supplementary Tables
The following four tables show simulation results.
Estimated power levels are for n trios simulated
10,000 times, with a type one error rate of 5 per
cent. Four methods of confounder adjustment were
employed: FEV , PPFEV , residuals from regressing
FEV on relevant covariates and residuals from
regressing PPFEV on relevant covariates. The per-
centage of variation explained by the covariates
used for within-study adjustment (R
2) is shown for
each of the covariate-adjusted phenotypes.
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# HENRY STEWART PUBLICATIONS 1479–7364. HUMAN GENOMICS. VOL 3. NO 4. 308–319 JULY 2009 315Table S1. Results from simulations in which the relationship between FEV and confounders was modelled using the CAMP data with no
truncation
N Heritability Allele
frequency
Power in population-based
design (%)
Power in family-based design
(%)
Avg. R
2
FEV PPFEV FEV
adj.
PPFEV
adj.
FEV PPFEV FEV
adj.
PPFEV
adj.
FEV
adj.
PPFEV
adj.
100 0.01 0.05 7.1 14.3 17.0 15.7 5.9 8.3 9.2 9.0 81.4 21.1
0.1 7.1 14.5 17.1 15.9 5.7 8.7 9.4 8.8 81.4 21.3
0.2 7.4 13.7 17.3 15.7 6.0 9.0 9.7 9.4 81.4 21.6
0.025 0.05 10.5 26.6 34.8 31.0 7.3 14.1 16.1 14.8 81.2 21.2
0.1 10.7 26.9 34.9 30.7 7.5 15.1 17.5 15.8 81.2 21.4
0.2 10.5 27.1 35.1 31.0 7.7 15.6 18.6 16.3 81.2 22.0
0.05 0.05 16.7 45.4 59.7 53.3 9.7 23.3 27.5 24.5 80.8 21.2
0.1 16.7 46.3 60.7 54.0 9.9 25.9 31.0 27.1 80.8 21.8
0.2 16.5 45.9 60.1 53.5 11.1 26.0 32.5 28.4 80.8 22.4
400 0.01 0.05 13.8 36.7 50.8 42.9 9.1 21.0 27.5 23.3 81.0 18.2
0.1 14.0 37.3 50.9 43.0 10.1 21.7 28.9 25.1 81.0 18.6
0.2 13.8 37.3 51.4 43.6 9.4 21.7 28.8 25.0 81.0 18.9
0.025 0.05 28.3 70.3 87.5 78.9 16.4 45.5 58.0 50.5 80.8 18.4
0.1 28.0 72.3 88.3 80.0 16.1 45.5 59.7 51.9 80.8 18.7
0.2 28.1 72.2 88.5 80.0 16.3 45.1 59.6 51.5 80.8 19.3
0.05 0.05 50.6 92.6 99.2 96.1 27.3 70.1 83.6 76.3 80.4 18.4
0.1 51.5 92.9 99.3 96.2 27.7 71.9 86.8 79.0 80.4 19.0
0.2 51.3 93.1 99.5 96.3 28.8 72.9 88.0 80.0 80.4 19.6
800 0.01 0.05 23.5 60.1 80.0 69.0 13.9 37.6 49.9 42.6 80.9 17.6
0.1 23.4 61.1 80.6 69.4 14.0 38.0 51.3 43.0 81.0 17.7
0.2 23.6 61.2 80.7 69.5 13.7 36.7 51.0 42.1 81.0 18.1
0.025 0.05 50.5 92.2 99.4 95.3 28.8 71.5 86.0 78.1 80.7 17.7
0.1 50.3 92.3 99.4 95.3 28.3 72.0 87.8 78.8 80.7 17.9
0.2 49.8 92.6 99.5 95.6 28.3 71.2 88.8 79.1 80.7 18.6
0.05 0.05 80.3 97.8 100.0 98.3 49.9 91.8 98.9 95.0 80.3 17.6
0.1 80.2 97.9 100.0 98.3 51.6 92.7 99.1 95.3 80.3 18.1
0.2 80.2 97.9 100.0 98.2 50.7 92.3 99.4 95.5 80.3 19.0
FEV, forced expiratory volume; PPFEV, percentage of predicted FEV.
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316 # HENRY STEWART PUBLICATIONS 1479–7364. HUMAN GENOMICS. VOL 3. NO 4. 308–319 JULY 2009Table S2. Results from simulations in which the relationship between FEV and confounders was determined by published FEV prediction
equations with no truncation
N Heritability Allele
frequency
Power in population-based
design (%)
Power in family-based design
(%)
Avg. R
2
FEV PPFEV FEV
adj.
PPFEV
adj.
FEV PPFEV FEV
adj.
PPFEV
adj.
FEV
adj.
PPFEV
adj.
100 0.01 0.05 6.9 15.6 17.0 16.5 5.5 9.0 9.3 9.1 84.4 6.6
0.1 6.4 15.9 16.9 16.8 5.4 9.5 9.3 9.5 84.5 6.6
0.2 6.6 15.7 16.6 16.5 6.0 9.7 9.6 9.6 84.4 6.8
0.025 0.05 9.7 31.4 32.8 32.3 6.7 16.0 15.7 15.4 84.2 6.7
0.1 9.7 32.2 34.1 33.4 7.1 16.9 17.0 16.7 84.3 6.7
0.2 8.9 31.4 33.7 32.3 7.5 18.2 18.2 17.7 84.2 6.8
0.05 0.05 14.6 56.2 59.3 57.2 8.7 27.0 26.8 26.0 84.0 6.8
0.1 14.6 56.3 59.1 57.1 8.9 29.8 30.2 29.0 83.9 6.8
0.2 14.3 57.5 60.3 58.3 10.0 31.3 31.6 30.8 83.9 6.8
400 0.01 0.05 12.2 46.9 49.5 47.3 8.2 25.4 26.2 25.3 84.1 2.1
0.1 12.5 45.9 49.5 46.1 9.1 26.7 28.3 26.9 84.1 2.2
0.2 12.5 47.6 50.6 47.7 8.5 27.1 27.9 26.9 84.1 2.2
0.025 0.05 24.1 84.5 86.7 84.7 14.2 54.5 56.6 54.0 83.9 2.2
0.1 23.6 83.7 86.3 84.1 13.8 55.9 58.4 55.8 83.9 2.2
0.2 24.1 84.8 87.4 85.0 13.9 55.7 58.1 55.5 83.9 2.3
0.05 0.05 43.3 98.0 99.1 98.1 23.2 80.9 82.6 80.4 83.6 2.2
0.1 43.1 98.5 99.4 98.6 23.4 83.6 85.7 83.2 83.5 2.3
0.2 43.0 98.7 99.3 98.8 24.3 84.4 86.8 84.0 83.5 2.4
800 0.01 0.05 20.3 73.9 77.6 74.3 12.4 46.6 48.6 46.0 84.0 1.3
0.1 19.3 75.8 79.1 75.9 12.2 47.2 49.8 47.0 84.1 1.3
0.2 20.0 75.6 79.0 75.8 11.9 47.0 49.4 46.6 84.0 1.3
0.025 0.05 43.3 98.1 99.2 98.2 24.5 82.9 84.9 82.5 83.9 1.3
0.1 42.7 98.2 99.2 98.2 23.8 84.5 86.8 84.4 83.8 1.3
0.2 42.2 98.0 99.3 98.1 23.6 84.6 87.2 84.5 83.8 1.4
0.05 0.05 71.0 99.6 100.0 99.6 41.9 97.7 98.7 97.6 83.5 1.3
0.1 71.5 99.6 100.0 99.6 43.4 98.2 99.0 98.0 83.5 1.4
0.2 71.7 99.5 100.0 99.5 42.7 98.4 99.3 98.3 83.5 1.4
FEV, forced expiratory volume; PPFEV, percentage of predicted FEV.
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# HENRY STEWART PUBLICATIONS 1479–7364. HUMAN GENOMICS. VOL 3. NO 4. 308–319 JULY 2009 317Table S3. Results from simulations in which the relationship between FEV and confounders was modelled using the CAMP data, and
phenotype data were truncated to exclude individuals with PPFEV  80 percent
N Heritability Allele
frequency
Power in population-based
design (%)
Power in family-based design
(%)
Avg. R
2 (%)
FEV PPFEV FEV
adj.
PPFEV
adj.
FEV PPFEV FEV
adj.
PPFEV
adj.
FEV
adj.
PPFEV
adj.
100 0.01 0.05 6.7 13.2 16.4 15.0 5.1 7.4 8.5 7.6 83.8 25.6
0.1 6.5 12.5 15.4 14.1 5.6 7.4 8.8 8.1 83.8 25.5
0.2 6.7 11.8 15.3 14.0 5.3 7.6 9.2 8.4 83.7 26.2
0.025 0.05 9.4 24.2 32.8 29.1 6.3 11.6 14.6 13.2 83.5 25.5
0.1 9.1 23.7 31.5 27.9 6.4 13.0 15.2 14.1 83.5 25.9
0.2 8.8 22.0 29.9 26.3 6.9 12.7 15.5 14.0 83.4 26.3
0.05 0.05 14.5 41.8 56.3 50.6 8.6 20.3 25.3 22.8 83.2 25.5
0.1 13.7 40.4 54.6 48.3 8.2 21.5 27.2 24.0 83.1 25.9
0.2 13.1 39.9 54.3 47.8 8.8 21.8 28.0 24.6 82.9 26.3
400 0.01 0.05 11.0 30.4 44.5 36.9 7.5 17.4 23.5 19.7 83.4 23.1
0.1 11.2 31.0 44.1 37.1 7.7 18.1 24.0 20.8 83.4 23.3
0.2 11.1 29.7 43.1 36.1 8.0 18.1 24.2 20.0 83.3 23.6
0.025 0.05 21.8 63.4 83.2 73.9 13.2 38.1 51.4 44.5 83.2 23.1
0.1 21.8 62.2 82.7 73.0 12.6 38.1 51.5 44.1 83.1 23.5
0.2 20.6 61.9 81.6 72.0 12.9 36.2 50.7 42.9 83.0 23.8
0.05 0.05 41.7 89.5 98.6 95.0 22.5 63.7 80.2 72.1 82.8 23.0
0.1 39.4 88.9 98.6 94.7 21.0 63.7 80.5 72.3 82.7 23.3
0.2 38.6 88.3 98.5 94.3 21.7 63.0 82.3 72.7 82.6 24.1
800 0.01 0.05 17.7 51.3 73.6 61.3 11.3 30.8 42.5 36.0 83.4 22.4
0.1 16.6 50.7 72.2 60.3 11.3 30.1 43.7 35.7 83.3 22.6
0.2 16.6 50.5 71.4 60.0 10.9 28.2 41.6 34.2 83.3 22.9
0.025 0.05 38.3 87.4 98.4 93.3 20.7 63.5 80.8 71.2 83.1 22.5
0.1 36.9 87.3 98.3 93.1 20.5 61.5 81.4 71.0 83.1 22.7
0.2 36.2 86.6 98.2 92.8 20.0 61.2 81.6 70.8 82.9 23.2
0.05 0.05 68.3 97.6 100.0 98.5 40.3 88.0 97.8 93.2 82.7 22.4
0.1 67.0 97.7 100.0 98.6 39.0 88.6 98.6 94.0 82.6 22.8
0.2 65.2 97.4 100.0 98.2 38.0 87.8 98.3 93.4 82.5 23.3
FEV, forced expiratory volume; PPFEV, percentage of predicted FEV.
PRIMARY RESEARCH Naylor, Weiss and Lange
318 # HENRY STEWART PUBLICATIONS 1479–7364. HUMAN GENOMICS. VOL 3. NO 4. 308–319 JULY 2009Table S4. Results from simulations in which the relationship between FEV and confounders was determined by published FEV prediction
equations and phenotype data was truncated to exclude individuals with PPFEV  80 percent
N Heritability Allele
frequency
Power in population-based
design (%)
Power in family-based design
(%)
Avg. R
2 (%)
FEV PPFEV FEV
adj.
PPFEV
adj.
FEV PPFEV FEV
adj.
PPFEV
adj.
FEV
adj.
PPFEV
adj.
100 0.01 0.05 6.5 14.6 15.2 15.3 4.6 8.5 8.6 8.2 85.5 7.5
0.1 5.8 14.3 14.4 15.1 5.5 8.8 8.9 8.5 85.5 7.6
0.2 6.1 13.8 14.7 14.6 5.6 9.4 9.4 9.2 85.4 7.9
0.025 0.05 8.8 30.4 31.2 31.5 5.9 14.3 14.3 13.9 85.3 7.7
0.1 8.4 29.5 30.5 30.3 6.6 15.8 15.8 15.5 85.3 7.9
0.2 7.7 28.5 29.5 29.4 6.3 15.7 15.6 15.1 85.3 8.0
0.05 0.05 12.2 52.6 53.8 53.8 7.3 24.7 23.9 24.0 84.9 7.8
0.1 11.7 52.8 54.4 53.6 7.6 26.9 26.9 26.2 84.9 8.1
0.2 10.7 50.8 52.9 52.5 7.8 27.5 27.5 26.9 84.9 8.3
400 0.01 0.05 10.1 41.6 43.1 42.3 6.9 22.3 22.7 22.2 85.2 4.3
0.1 9.2 41.5 42.9 41.9 6.8 22.9 23.0 23.0 85.1 4.3
0.2 8.7 40.1 40.7 40.3 6.7 23.1 23.2 22.9 85.1 4.4
0.025 0.05 17.3 79.8 81.8 80.8 10.4 48.3 49.1 48.0 85.0 4.3
0.1 16.5 79.8 81.6 80.5 10.2 49.1 50.0 48.7 85.0 4.5
0.2 16.6 78.5 80.0 78.8 10.2 48.0 49.4 47.9 84.9 4.6
0.05 0.05 32.0 97.6 98.4 97.8 17.0 77.1 78.5 77.2 84.6 4.5
0.1 30.3 97.4 98.2 97.7 17.1 78.5 80.0 78.4 84.6 4.7
0.2 29.2 97.7 98.3 97.9 16.9 78.5 80.4 78.6 84.5 4.9
800 0.01 0.05 13.9 69.6 72.1 69.9 9.5 40.2 41.2 40.1 85.1 3.6
0.1 13.1 68.3 69.9 68.4 8.7 40.5 41.8 40.5 85.1 3.7
0.2 13.4 67.8 70.5 68.2 8.7 39.7 41.3 40.1 85.1 3.8
0.025 0.05 30.2 97.1 97.9 97.3 16.6 77.3 79.1 77.6 84.9 3.7
0.1 27.7 97.3 98.1 97.3 15.5 78.0 79.7 78.1 84.9 3.8
0.2 26.5 96.8 97.8 96.8 15.5 78.4 80.5 78.7 84.8 4.0
0.05 0.05 55.6 99.7 100.0 99.7 30.9 96.4 97.5 96.5 84.6 3.9
0.1 52.1 99.6 100.0 99.6 29.6 97.1 98.0 97.3 84.5 4.0
0.2 51.4 99.6 100.0 99.6 29.3 96.8 97.9 97.0 84.5 4.3
FEV, forced expiratory volume; PPFEV, percentage of predicted FEV.
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